
Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …

Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

